Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:07 AM
Ignite Modification Date:
2025-12-25 @ 1:07 AM
NCT ID:
NCT00964093
Eligibility Criteria:
Inclusion Criteria:
1. Infants with birth weights between 500 and 1500 grams admitted to the NICU with any of the following lines will be eligible for inclusion in this study
1. umbilical arterial line (UAL)
2. umbilical venous line (UVL)
3. peripheral arterial line (PAL)
4. peripheral long line (PLL)
5. central venous line (CVL)
2. Each eligible subject will be randomized to receive either standard of care or silver alginate dressing. Dressings will be changed every 7 days in accordance to current facility protocols.
Exclusion Criteria:
1\. Any infant born with a lethal abnormality or who has received topical Silver therapy will be excluded from the study.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
1 Day
Maximum Age:
3 Weeks
Study:
NCT00964093
Study Brief:
Protocol Section:
NCT00964093